The overdose-reversal drug should be more widely available, health experts have said. It arrives in many stores next week, no prescription necessary.
Category: Drugs (Pharmaceuticals)
-
Eliquis and Jardiance Among First Drugs Picked for Medicare Price Negotiations
The Biden administration’s announcement was an important moment for Democrats, who have campaigned on a promise to lower the cost of prescription drugs.
-
Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.
-
Wegovy, the Weight Loss Drug, Relieves Heart Failure Symptoms: Drugmaker’s Study
The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.
-
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billion
Mallinckrodt Pharmaceuticals had promised $1.7 billion to governments, individuals and others harmed by the opioid crisis.
-
Expert Panel Recommends New Drugs for HIV Prevention
The “grade A” endorsement means that two additional drugs should be covered under the Affordable Care Act.
-
Opioid Settlement Money Is Being Spent on Police Cars and Overtime
As states and counties spend the first wave of billions of dollars from the pharmaceutical industry, public health groups are challenging how some funds are being used.
-
Should Opioid Settlement Money Be Spent on Law Enforcement?
As states and counties spend the first wave of billions of dollars from the pharmaceutical industry, public health groups are challenging how some funds are being used.
-
Research Trials Halted at Columbia’s Psychiatric Center After Suicide
Human research trials at the New York State Psychiatric Institute at Columbia have been paused while regulators review whether protocols were violated.
-
FDA Approves First Pill for Postpartum Depression
Because the pill works faster than other antidepressants and is taken for only two weeks, it may encourage more treatment of the debilitating condition.
-
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations
The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
-
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.